Subsequent studies by several groups, including ours, have identified mutations in additional genes, e.g. RPS15, NFKBIE and EGR2, revealing a much more complicated genetic landscape for CLL (34–36). The gene discussed is EGR2; the disease is B-cell chronic lymphocytic leukemia.